2 massive drugmakers are locked in a battle over the market for cancer immunotherapy — Goldman analysts say one is pulling ahead

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

इंडिया समाचार समाचार

इंडिया ताज़ा खबर,इंडिया मुख्य बातें

Pharma giants Merck and Bristol-Myers Squibb are fighting for dominance in the multi-billion dollar cancer immunotherapy market.

 

आपकी टिप्पणी के लिए धन्यवाद। आपकी टिप्पणी समीक्षा के बाद प्रकाशित की जाएगी।

Behind pay wall.. nice trick

हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

 /  🏆 729. in İN

इंडिया ताज़ा खबर, इंडिया मुख्य बातें

Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।

Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and moreDrugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants.
स्रोत: MarketWatch - 🏆 3. / 97 और पढो »

Pharma Industry Pushes Back Against Required Listing of Drug Prices in TV AdsThe pharmaceutical industry is signaling resistance to a Trump administration plan to require that the list price be included for most drugs in television ads, setting the stage for a protracted fight over a proposal with broad bipartisan support. JUST MAKE IT LAW, THEY HAVE THE MONEY. What could be wrong with this? Pharma, why are you upset with telling consumers how much you are going to cost? Is it that you are worried that we will be pissed off with price gouging like the Epi-pen CEO did? Truth in advertising, what a concept!
स्रोत: WSJ - 🏆 98. / 63 और पढो »